Top Markets
Coin of the day
YS Biopharma Co., Ltd. YS Biopharma Co., Ltd.

YS Biopharma Co., Ltd.

YS
Rank in Stocks #30057
YS Biopharma Co., Ltd., a biopharmaceutical firm established in Beijing, China,... YS Biopharma Co., Ltd., a biopharmaceutical firm established in Beijing, China, in 2002, specializes in the discovery, development, production, and commercialization of vaccines and therapeutic biologics. Their primary focus is on addressing infectious diseases and cancer. Central to their efforts is a proprietary PIKA immunomodulating technology platform, which supports the creation of preventive and therapeutic biologics for conditions such as Rabies, Coronavirus, Hepatitis B, Influenza, and Shingles. The company extends its operations across multiple countries, including China, the United States, Singapore, the United Arab Emirates, and the Philippines.
Share Price
$0.715
Last synced: 2024-06-18
Market Cap
$18.41M
Change (1 day)
3.61%
Change (1 year)
0.00%
Country
CN
Trade YS Biopharma Co., Ltd. (YS)

Category

Operating Margin for YS Biopharma Co., Ltd. (YS)
Operating Margin as of 2026 TTM: 0.00%
According to YS Biopharma Co., Ltd. latest financial reports and stock price the company's current Operating Margin (TTM) is 0.00%. At the end of 2026 the company had an Operating Margin of 0.00%.
Operating Margin history for YS Biopharma Co., Ltd. from 2026 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
Not enough data for the provided dates.
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
38.59% -
US
28.81% -
NL
25.72% -
AU
0.00% -
CH
0.00% -
KR
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.